AL-amyloidosis after coronavirus infection with acute atypical heart injury

Abstract

The emergence of effective therapy for AL amyloidosis with cardiac involvement raises the challenge of a comprehensive assessment of the risk of SCD and its prevention. This problem should be approached individually and the possibility of ICD implantation should be considered in patients with ventricular arrhythmias: frequent extrasystoles and unstable ventricular tachycardia. With the development of rhythm and conduction disturbances in patients with amyloidosis, one should keep in mind the possibility of myocarditis, and in patients who have suffered a new coronavirus infection, its possible role in the induction of both post-Covid myocarditis and amyloidosis itself.